QCG
APLT

Quadrant Capital Group’s Applied Therapeutics APLT Stock Holding History

Quadrant Capital Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-113
Closed -$1K – 2489
2021
Q4 		$1K Buy
+113
New +$1.48K ﹤0.01% 2239

Other funds holding APLT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's APLT Position: Q1 2022 in Review

Quadrant Capital Group sold out of Applied Therapeutics (APLT) in Q1 2022, closing a stake of 113 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in APLT in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

  • Quadrant Capital Group reported no remaining Applied Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 113 Applied Therapeutics shares in Q1 2022, an estimated $1K.
  • Quadrant Capital Group first reported a position in Applied Therapeutics in Q4 2021 and held it in 1 quarter.
  • Quadrant Capital Group's Applied Therapeutics position peaked at $1K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.